Circadian changes in core body temperature, metabolic rate and locomotor activity in rats on a high-protein, carbohydrate-free diet.
Ingestion of a high-protein meal results in body weight loss due to elevated energy expenditure, while also increasing satiety and decreasing subsequent food intake. The present study aimed to clarify the effects of a high-protein, carbohydrate-free diet (HPCFD) on these physiological indicators from a circadian perspective. Rats were given HPCFD or a pair-fed normal protein content diet (20% protein; NPD) for 4 d. The HPCFD group lost more body weight than the NPD group. Oxygen consumption (VO(2)) in the HPCFD group did not change during the experimental period, and tended to be higher during the light (L) phase than in the NPD group. Carbon dioxide production (VCO(2)) during the L phase was higher in the HPCFD group than in the NPD group, where VCO(2) was gradually decreased during the last dark (D) phase and throughout the L phase. The HPCFD group exhibited higher daily core body temperature (T(b)), particularly during the late D phase and throughout the L phase when compared to the NPD group. Locomotor activities during the D phase of the NPD group tended to gradually increase and were thus significantly higher than in the HPCFD group. These results suggest that HPCFD, even if energy intake is insufficient, maintains circadian changes in metabolic rates, resulting in maintenance of elevated daily T(b) and body weight reduction without increasing activity.
Yamaoka
Ippei
I
Research and Development Center, New Business and Development Department, Otsuka Pharmaceutical Factory, Inc, Naruto, Tokushima, Japan. yamaokih@otsukakj.co.jp
Hagi
Mieko
M
Doi
Masako
M
D000818:Animals; D001481:Basal Metabolism / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D002245:Carbon Dioxide / Q000378:metabolism; D002940:Circadian Rhythm / Q000187:drug effects*; D003624:Darkness; D050528:Diet, Carbohydrate-Restricted; D004044:Dietary Proteins / Q000494:pharmacology*; D008027:Light; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D015431:Weight Loss / Q000187:drug effects*
D004044:Dietary Proteins; D002245:Carbon Dioxide; D010100:Oxygen